Total Payments
$9,391
2024 Payments
$544.77
Companies
37
Transactions
493
Medicare Patients
1,973
Medicare Billing
$243,628
Payment Breakdown by Category
Food & Beverage$8,584 (91.4%)
Consulting$500.00 (5.3%)
Education$306.95 (3.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,584 | 486 | 91.4% |
| Consulting Fee | $500.00 | 1 | 5.3% |
| Education | $306.95 | 6 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,134 | 69 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,072 | 44 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $855.44 | 72 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $804.04 | 51 | $0 (2024) |
| Astellas Pharma US Inc | $778.79 | 36 | $0 (2024) |
| PFIZER INC. | $661.21 | 20 | $0 (2024) |
| Promius Pharma LLC | $619.80 | 2 | $0 (2018) |
| Merck Sharp & Dohme LLC | $398.73 | 19 | $0 (2023) |
| AbbVie Inc. | $333.70 | 27 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $288.76 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $544.77 | 32 | Novartis Pharmaceuticals Corporation ($137.49) |
| 2023 | $1,076 | 46 | Merck Sharp & Dohme LLC ($228.92) |
| 2022 | $850.39 | 47 | Astellas Pharma US Inc ($306.02) |
| 2021 | $1,357 | 78 | Biogen, Inc. ($168.64) |
| 2020 | $982.38 | 56 | Janssen Pharmaceuticals, Inc ($240.07) |
| 2019 | $1,119 | 67 | Janssen Pharmaceuticals, Inc ($358.56) |
| 2018 | $1,813 | 71 | Promius Pharma LLC ($619.80) |
| 2017 | $1,648 | 96 | PFIZER INC. ($509.16) |
All Payment Transactions
493 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: VACCINES | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $7.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Oncology | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $4.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $111.15 | General |
| Category: Cardiology | ||||||
| 08/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Cardiology | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $4.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $7.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Respiratory | ||||||
| 05/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Cardio-renal | ||||||
| 05/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/01/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $5.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/30/2024 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: NEUROLOGY | ||||||
| 04/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.09 | General |
| Category: PSYCHIATRY | ||||||
| 04/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Inflammation | ||||||
| 04/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/05/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: ANTIBIOTIC | ||||||
| 03/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Diabetes | ||||||
| 03/15/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: ANTIBIOTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 394 | 782 | $128,955 | $53,667 |
| 2022 | 10 | 502 | 840 | $138,165 | $55,617 |
| 2021 | 10 | 548 | 942 | $168,745 | $68,369 |
| 2020 | 9 | 529 | 1,122 | $175,220 | $65,975 |
Total Patients
1,973
Total Services
3,686
Medicare Billing
$243,628
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 110 | 342 | $42,750 | $16,259 | 38.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 174 | $34,850 | $13,476 | 38.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 73 | 128 | $21,120 | $9,987 | 47.3% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 59 | 62 | $15,810 | $8,217 | 52.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 29 | 30 | $6,150 | $2,688 | 43.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 16 | $4,375 | $1,880 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 30 | $3,900 | $1,159 | 29.7% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 135 | 373 | $46,625 | $16,440 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 131 | $26,400 | $11,591 | 43.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 62 | 63 | $16,065 | $7,493 | 46.6% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 69 | 102 | $16,830 | $6,660 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 31 | 31 | $8,280 | $3,938 | 47.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 17 | 17 | $6,375 | $2,805 | 44.0% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Office | 2022 | 43 | 43 | $7,310 | $2,553 | 34.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 48 | $6,240 | $2,486 | 39.8% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 16 | 18 | $3,690 | $1,602 | 43.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 13 | 14 | $350.00 | $48.07 | 13.7% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 148 | 428 | $53,500 | $20,555 | 38.4% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Office | 2021 | 98 | 102 | $26,010 | $12,353 | 47.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 136 | $27,550 | $11,559 | 42.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 70 | 100 | $17,550 | $6,363 | 36.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 35 | 35 | $9,000 | $4,608 | 51.2% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 17 | 18 | $12,420 | $3,993 | 32.2% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Office | 2021 | 44 | 44 | $7,480 | $2,781 | 37.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 34 | 48 | $6,240 | $2,424 | 38.8% |
About Dr. David Abbott, MD
Dr. David Abbott, MD is a Internal Medicine healthcare provider based in Richmond Heights, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1568448850.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Abbott, MD has received a total of $9,391 in payments from pharmaceutical and medical device companies, with $544.77 received in 2024. These payments were reported across 493 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($8,584).
As a Medicare-enrolled provider, Abbott has provided services to 1,973 Medicare beneficiaries, totaling 3,686 services with total Medicare billing of $243,628. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Richmond Heights, MO
- Active Since 12/19/2005
- Last Updated 02/01/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568448850
Products in Payments
- XARELTO (Drug) $1,003
- ENTRESTO (Drug) $622.41
- Zembrace (Drug) $619.80
- Ozempic (Drug) $517.96
- APTIOM (Drug) $486.70
- VRAYLAR (Drug) $222.58
- TRULICITY (Drug) $205.29
- Myrbetriq (Drug) $199.86
- Victoza (Drug) $197.73
- Tresiba (Drug) $197.57
- QULIPTA (Drug) $192.34
- Kerendia (Drug) $189.51
- NURTEC ODT (Drug) $186.64
- LEQVIO (Drug) $181.63
- MYRBETRIQ (Drug) $172.16
- BELSOMRA (Drug) $155.89
- CHANTIX (Drug) $155.18
- REXULTI (Drug) $152.92
- VERQUVO (Drug) $144.10
- EUCRISA (Drug) $142.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Richmond Heights
Divya Motkur, M.d, M.D
Internal Medicine — Payments: $1,480
Internal Medicine $1,480
Jacob Scharlotte, Do, DO
Internal Medicine — Payments: $174.13
Internal Medicine $174.13
Sean Michael Villaflores, Md, MD
Internal Medicine — Payments: $136.56
Internal Medicine $136.56
Walter Woodruff, Do, DO
Internal Medicine — Payments: $126.20
Internal Medicine $126.20
Julie Alderson, D.o, D.O
Internal Medicine — Payments: $116.72
Internal Medicine $116.72
Seba Hasan, M.d, M.D
Internal Medicine — Payments: $114.26
Internal Medicine $114.26